JAK1 Activates STAT3 Activity in Non-Small–Cell Lung Cancer Cells and IL-6 Neutralizing Antibodies Can Suppress JAK1-STAT3 SignalingLanxi Song(Moffitt Cancer Center), Eric B. Haura(Moffitt Cancer Center)Molecular Cancer TherapeuticsJanuary 8, 201110.1158/1535-7163.mct-10-0502Cited by 180SaveCiteExport RISWatch citationsRelated PapersZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer|PLoS ONE|2016|98Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry–Based Phosphotyrosine Proteomics|Clinical Cancer Research|2016|24